Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
Newborn bloodspot screening (NBS) for cystic fibrosis (CF) is an effective strategy for the early recognition of infants with a CF diagnosis. Some infants with a positive NBS result for CF have an inconclusive diagnosis and evidence suggests the number of these infants is increasing, as more extensi...
Enregistré dans:
Auteurs principaux: | Aditi Sinha, Kevin W. Southern |
---|---|
Format: | article |
Langue: | EN |
Publié: |
European Respiratory Society
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3517d47adcba4f58b4ead0de31342077 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
par: Maryam Hassanzad, et autres
Publié: (2021) -
Delayed HIV diagnosis in a cystic fibrosis patient: Not just another exacerbation
par: Sapna Bhatia, et autres
Publié: (2021) -
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
par: Schmidt BZ, et autres
Publié: (2016) -
Acquired cystic fibrosis transmembrane conductance regulator dysfunction
par: Catherine Banks, et autres
Publié: (2018) -
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
par: Serena Schippa, et autres
Publié: (2013)